Learn about Hydrea (Hydroxyurea) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Differentiation Syndrome. In the clinical trial, 14% of patients treated with IDHIFA experienced differentiation syndrome, which may be life-threatening or fatal if not treated. The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor. Cymevene 500 mg powder for concentrate for solution for Infusion - Patient Information Leaflet (PIL) by Roche Products Limited Hydroxyurea (Hydrea) is used alone or with other medications or radiation therapy to treat a certain type of chronic myelogenous leukemia (CML; a type of cancer of the white blood cells) and certain types of head and neck cancer (including cancer of the mouth, cheek, tongue, throat, tonsils, and sinuses). Learn about Zerit (Stavudine) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Hydrea - Clinical Pharmacology Mechanism of Action. The precise mechanism by which hydroxyurea produces its antineoplastic effects cannot, at present, be described. Siklos ® (hydroxyurea) tablets, for oral use WHAT IS SIKLOS ®? Siklos ® is a prescription medicine that is used to reduce the frequency of painful crises and reduce the need for blood transfusions in children, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises. We recommend contouring of target volumes. Lim et al r provide some guidelines for contouring of target volumes on MRI, most of which can be extrapolated to CT. Hydroxyurea capsules are indicated for the treatment of: Resistant chronic myeloid leukemia. Locally advanced squamous cell carcinomas of the head and neck (excluding the lip) in combination with chemoradiation.